We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nalge Nunc to Market BioCrystal's OptiCell

By HospiMedica staff writers
Posted on 21 Aug 2006
Nalge Nunc International Corporation (Rochester, NY, USA) has entered into a partnership with BioCrystal, Ltd. More...
(Westerville, OH, USA) and acquired global distribution rights of OptiCell and related new products. OptiCell was developed by BioCrystal for cell cultures. The product will be sold and supported globally through the Nalge Nunc international distribution network under the brand name Nunc OptiCell.

The OptiCell device consists of gas-permeable polymer membranes that provide a cell culture growth surface area enclosed within a sealed environment. It accommodates adherent or non-adherent cells and enables visual access to living cells using standard imaging equipment. OptiCell's culture chamber enables cell growth on two parallel, gas-permeable membranes with only 10 ml of cell culture media or reagents.

A rack of 20 OptiCells provides growth surface equivalent to 27 T-75 (75 cm2) culture flasks, in one-fifth the incubation space. Self-sealing access ports greatly reduce risk of contamination, and the clear crystal polystyrene membrane allows high quality imaging of cells. Membranes can be sectioned, making OptiCell useful for cytostaining, transfection, and single cell cloning. The device is ideal for continuous monoclonal antibody production.

Nalge Nunc International is engaged in the design, development, and manufacture of plastic products for use in labware, packaging, biotechnology, and life science applications. "We are pleased to have joined with BioCrystal in bringing this exciting technology to the biomedical research community,” said Steve Silverman, vice president, marketing and product development, Nalge Nunc. "OptiCell further expands the available technologies we provide for in vitro cell culture,” he added.



Related Links:
Nalge Nunc
BioCrystal

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.